Bertil Aberg

Title: Bertil Aberg: Innovator in Genetic Engineering

Introduction

Bertil Aberg is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of genetic engineering, particularly in the development of artificial genes. His work has implications for the production of authentic human serum albumin, a vital protein in medical applications.

Latest Patents

Bertil Aberg holds a patent for an artificial gene coding for authentic human serum albumin. This patent describes a structural gene that is optionally supplemented by an upstream triplet coding for methionine and can be extended by a synthetic prepro-leader-coding sequence. The codons of the nucleotide sequence are specifically selected for expression in a non-human host, such as yeast. The patent also discloses methods for producing the gene, a recombinant DNA molecule containing the structural gene inserted into a vector, and a host transformed with this recombinant DNA molecule. Furthermore, it outlines a method for producing authentic human serum albumin and the resulting pharmaceutical compositions.

Career Highlights

Throughout his career, Bertil Aberg has worked with various organizations, including Skandigen AB and MTA Szegedi Biológiai Központja. His experience in these companies has allowed him to advance his research and contribute to the field of biotechnology.

Collaborations

Bertil Aberg has collaborated with notable professionals in his field, including Andras Simoncsits and Miklos Kalman. These collaborations have enriched his research and expanded the impact of his innovations.

Conclusion

Bertil Aberg's work in genetic engineering, particularly his patent for artificial gene coding for authentic human serum albumin, showcases his innovative spirit and dedication to advancing medical science. His contributions continue to influence the field and hold promise for future developments.